http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Stability criterion and its calculation for sail-assisted ship
Yihuai Hu,Juanjuan Tang,Shuye Xue,Shewen Liu 대한조선학회 2015 International Journal of Naval Architecture and Oc Vol.7 No.1
Stability criterion and its calculation are the crucial issue in the application of sail-assisted ship. However, there is at present no specific criterion and computational methods for the stability of sail-assisted ship. Based on the stability requirements for seagoing ships, the stability criterion of the sail-assisted ships is suggested in this paper. Furthermore, how to calculate the parameters and determine some specific coefficients for the ship stability calculation, as well as how to redraw stability curve are also discussed in this paper. Finally, to give an illustration, the proposed method is applied on a sail assisted-ship model with comments and recommendations for improvement.
Yihuai Gao,He Gao,Eli Chan,Wenbo Tan,Jin Lan,Hwee-Ling Koh,Guoliang Chen,Shufeng Zhou 한국식품영양과학회 2004 Preventive Nutrition and Food Science Vol.9 No.3
A recent randomized and double-blind placebo-controlled clinical study has indicated that Ganoderma lucidum polysaccharides (GLP) decrease blood glucose in patients with type II diabetes. The aim of this study was to investigate the effect of the GLP extract in alloxan-induced diabetic rats. Oral administration of GLP at 0.25, 0.5 and 1.0 g/kg for 4 weeks resulted in a reduction of blood glucose levels by 12.5, 18.7 and 33.7% respectively, while glibenclamide treatment brought the hyperglycemic value down to normal. The hypoglycemic effect was supported by a significant decrease in glycosylated haemoglobin and increased plasma insulin levels (p<0.01) in a dose- and time-dependent manner. This study showed that GLP has similar hypoglycemic effects as glibenclamide in alloxan-induced diabetic rats.
Stability criterion and its calculation for sail-assisted ship
Hu, Yihuai,Tang, Juanjuan,Xue, Shuye,Liu, Shewen The Society of Naval Architects of Korea 2015 International Journal of Naval Architecture and Oc Vol.7 No.1
Stability criterion and its calculation are the crucial issue in the application of sail-assisted ship. However, there is at present no specific criterion and computational methods for the stability of sail-assisted ship. Based on the stability requirements for seagoing ships, the stability criterion of the sail-assisted ships is suggested in this paper. Furthermore, how to calculate the parameters and determine some specific coefficients for the ship stability calculation, as well as how to redraw stability curve are also discussed in this paper. Finally, to give an illustration, the proposed method is applied on a sail assisted-ship model with comments and recommendations for improvement.
Gao, Yihuai,Gao, He,Chan, Eli,Tan, Wenbo,Lan, Jin,Koh, Hwee-Ling,Chen, Guoliang,Zhou, Shufeng The Korean Society of Food Science and Nutrition 2004 Preventive Nutrition and Food Science Vol.9 No.3
A recent randomized and double-blind placebo-controlled clinical study bas indicated that Ganoderma lucidum polysaccharides (GLP) decrease blood glucose in patients with type II diabetes. The aim of this study was to investigate the effect of the GLP extract in alloxan-induced diabetic rats. Oral administration of GLP at 0.25, 0.5 and 1.0 g/kg for 4 weeks resulted in a reduction of blood glucose levels by 12.5, 18.7 and 33.7% respectively, while glibenclamide treatment brought the hyperglycemic value down to normal. The hyperglycemic effect was supported by a significant decrease in glycosylated haemoglobin and increased plasma insulin levels (p<0.01) in a dose- and time-dependent manner. This study showed that GLP has similar hypoglycemic effects as glibenclamide in alloxan-induced diabetic rats.
Shufeng Zhou,Yihuai Gao,Wenbo Tang,Xihu Dai,He Gao,Guoliang Chen,Jinxian Ye,Eli Chan,Hwee Lling Koh,Xiaotian Li 한국식품영양과학회 2005 Journal of medicinal food Vol.8 No.2
Preclinical studies have established that the polysaccharide fractions of Ganoderma lucidumhave potential an-titumor activity. Recent clinical studies have demonstrated that G. lucidumpolysaccharides enhance host immune functions[e.g., enhanced natural killer (NK) cell activity] in patients with advanced solid tumors, although an objective response wasnot observed. This open-label study aimed to evaluate the effects of water-soluble G. lucidumpolysaccharides (Ganopoly??,Encore International Corp., Auckland, New Zealand) on immune functions in patients with advanced lung cancer. Thirty-sixpatients were enrolled and treated with 5.4 g/day Ganopoly for 12 weeks. In the 30 cancer patients who completed the trial,treatment with Ganopoly did not significantly alter the mean mitogenic reactivity to phytohemagglutinin, mean counts of CD3,CD4, CD8, and CD56, mean plasma concentrations of interleukin (IL)-2, IL-6, and interferon (IFN)-., or NK activity in thepatients, but the results were significantly variable. However, some cancer patients demonstrated markedly modulated im-mune functions. The changes in IL-1 were correlated with those for IL-6, IFN-., CD3, CD8, and NK activity (P. .05), andIL-2 changes were correlated with those for IL-6, CD8, and NK activity. The results suggest that subgroups of cancer patientsmight be responsive to Ganopoly in combination with chemotherapy/radiotherapy. Further studies are needed to explore theefficacy and safety of Ganopoly used alone or in combination with chemotherapy/radiotherapy in lung cancer patients.